Non-receipt of guideline-concordant treatment in pancreatic cancer is linked to worse outcomes and distinct patient patterns.

• 32.4% of patients in a study cohort did not receive guideline-concordant treatment.
• Key factors include socioeconomic status, access to care, and patient vulnerability at first contact.

Addressing these factors may improve treatment access and outcomes.

• Areas with higher deprivation indices showed increased non-receipt, especially in emergency department patients.

Surgeons need to know that bile leaks and Klebsiella pneumoniae infections are major predictors of severe postpancreatectomy hemorrhage in patients with postoperative pancreatic fistulas.

• Postpancreatectomy hemorrhage occurred in 7.8% of patients, with grade b/c complications in 5.2%.
• The pancreaticojejunal anastomosis was the most frequent bleeding source (15.6%), followed by branches of the superior mesenteric artery (9.6%).

Understanding these predictors can enhance surgical decision-making and outcomes in high-risk patients.

• Cryptogenic hemorrhage made up 24.7% of grade b/c cases but was linked to lower mortality compared to other sources.

A new three-tier nodal classification improves survival predictions for intrahepatic cholangiocarcinoma patients post-surgery.

• Median overall survival drops significantly: 55.3 months (n0) to 19.0 months (n2) (p < 0.001).
• Node-positive patients (n1, n2) face worse outcomes (HR 2.01 and HR 2.59, respectively) compared to node-negative (n0).

Use this refined staging to guide treatment decisions, especially for chemotherapy selection in node-positive cases.

• Adjuvant chemotherapy offers node-positive patients an additional survival benefit (5.2 months for n1, 4.0 months for n2) versus 1.4 months for node-negative patients.

Neuroendocrine liver metastases are seeing better surgical outcomes as practices shift over the last two decades.

• In the later cohort (2009-2023), major hepatectomy dropped to 32.9%, compared to 60.0% (p < 0.001) in the earlier cohort (1998-2008).
• The 10-year overall survival improved significantly from 44.2% to 67.4% (p < 0.001).

Surgeons should consider parenchyma-sparing approaches and modern therapies for better patient outcomes.

• Local therapies and targeted agents were used more frequently in the later cohort after tumor progression.

Postoperative acute pancreatitis affects recovery after pancreatoduodenectomy—understanding its definitions can optimize patient management.

• Incidence of postoperative acute pancreatitis: 11.9% (ISGPS), 41.2% (Atlanta-adapted), and 17.6% (Connor’s definition).
• The Atlanta-adapted framework showed the best ability to predict severe complications (AUC 0.68).
• A new graded Atlanta-Helsinki classification correlates with complication rates: 12.3% (none), up to 56.3% (both criteria).

Adopting this classification can refine decision-making and improve patient outcomes post-surgery.